Annora Pharma Private Limited: Lacosamide Tablets, Usp, C V, 100mg
Recall Summary Annora Pharma is recalling Lacosamide Tablets USP, 100mg (60-count bottles, NDC 31722-813-60) distributed nationwide because some bottles may contain Selexipag 1000 mcg tablets mixed in by mistake. The recalled medication was manufactured for Camber Pharmaceuticals and distributed across all U.S. states and Washington D.C. This is a Class II recall, meaning the situation could cause adverse health effects.
- Recalling firm
- Annora Pharma Private Limited
- Product
- Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
- Reason
- Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-06-04
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/84015caa-27a2-466b-ac10-307892bc2958